Pei You-Juan, Wang Ai-Ming, Zhao Yong, Yan Ling, Li Min, White Richard E, Han Gui Chun
Reproductive Medical Center of Navy General Hospital, Hai Dian District , Beijing , China .
Gynecol Endocrinol. 2014 Aug;30(8):553-6. doi: 10.3109/09513590.2013.829443. Epub 2014 Jun 2.
To investigate cardiovascular risk factors in women with polycystic ovary syndrome (PCOS) combined with subclinical hypothyroidism (SCH).
A place-controlled study was performed. Group 1: 29 patients with PCOS and SCH; Group II: 35 patients with PCOS and normal thyroid function; and Group III: 34 healthy women with normal thyroid function. MAIN MEASURE INDEXES: Total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and high-density lipoprotein (HDL), Carotid Arterial Intima-Media Thickness (CIMT), free triiodothyronine 3 (FT3), free triiodothyronine 4 (FT4), thyroid stimulating hormone (TSH), fasting glucose, 1-hour oral glucose tolerance test (OGTT1), 2-hour oral glucose tolerance test (OGTT2), fasting insulin, insulin after 1 hour oral glucose (INS1), insulin after 2 h oral glucose (INS2), HOM-IR = (fasting glucose × fasting insulin)/22.5.
TG, TC FIN, INS1, and HOM-IR levels were significantly higher, but the mean HDL level was significantly lower in Group I than in Group II (p < 0.05). LDL cholesterol, FGOGTT1, OGTT2, and insulin after 2 h oral glucose were not significantly higher in Group I than in Group II (p > 0.05). TG, TC, FIN and INS contents 2 h meal, HOM-IR levels were significantly higher, and the mean HDL cholesterol level was significantly lower in Group I than in Group III (p < 0.05). Blood glucose levels after 1 and 2 h were not significantly higher in Group I than in the Group III (p > 0.05). Carotid Arterial Intima-Media Thickness (CIMT) was significantly thicker in Group I than other two groups.
The PCOS patients combined with SCH have higher risk of cardiovascular risk factors than in controls or in patients with PCOS.
研究多囊卵巢综合征(PCOS)合并亚临床甲状腺功能减退(SCH)女性的心血管危险因素。
进行了一项对照研究。第一组:29例PCOS合并SCH患者;第二组:35例PCOS且甲状腺功能正常的患者;第三组:34例甲状腺功能正常的健康女性。主要测量指标:总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)和高密度脂蛋白(HDL)、颈动脉内膜中层厚度(CIMT)、游离三碘甲状腺原氨酸3(FT3)、游离甲状腺素4(FT4)、促甲状腺激素(TSH)、空腹血糖、口服葡萄糖耐量试验1小时(OGTT1)、口服葡萄糖耐量试验2小时(OGTT2)、空腹胰岛素、口服葡萄糖1小时后胰岛素(INS1)、口服葡萄糖2小时后胰岛素(INS2)、HOM-IR =(空腹血糖×空腹胰岛素)/22.5。
第一组的TG、TC、FIN、INS1和HOM-IR水平显著更高,但平均HDL水平显著低于第二组(p < 0.05)。第一组的LDL胆固醇、FGOGTT1、OGTT2和口服葡萄糖2小时后胰岛素水平与第二组相比无显著升高(p > 0.05)。第一组的TG、TC、FIN和餐后2小时INS含量、HOM-IR水平显著更高,且平均HDL胆固醇水平显著低于第三组(p < 0.05)。第一组1小时和2小时后的血糖水平与第三组相比无显著升高(p > 0.05)。第一组的颈动脉内膜中层厚度(CIMT)比其他两组显著更厚。
PCOS合并SCH的患者比对照组或PCOS患者具有更高的心血管危险因素风险。